These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 2913120)

  • 21. Long-term efficacy and toxicity of high-dose amiodarone therapy for ventricular tachycardia or ventricular fibrillation.
    Morady F; Sauve MJ; Malone P; Shen EN; Schwartz AB; Bhandari A; Keung E; Sung RJ; Scheinman MM
    Am J Cardiol; 1983 Nov; 52(8):975-9. PubMed ID: 6637851
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Five-year follow-up of 589 patients treated with amiodarone.
    Weinberg BA; Miles WM; Klein LS; Bolander JE; Dusman RE; Stanton MS; Heger JJ; Langefeld C; Zipes DP
    Am Heart J; 1993 Jan; 125(1):109-20. PubMed ID: 8417505
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Predictive value of early electrophysiologic testing in determining long-term outcome with amiodarone treatment in patients with sustained ventricular tachycardia.
    Shannon JA; Hammill SC; Gersh BJ
    Mayo Clin Proc; 1991 Nov; 66(11):1114-9. PubMed ID: 1943242
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Efficacy and tolerance of high-dose intravenous amiodarone for recurrent, refractory ventricular tachycardia.
    Mooss AN; Mohiuddin SM; Hee TT; Esterbrooks DJ; Hilleman DE; Rovang KS; Sketch MH
    Am J Cardiol; 1990 Mar; 65(9):609-14. PubMed ID: 2178383
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Amiodarone and sustained ventricular arrhythmias: statistical evidence of drug effectiveness.
    Flaker GC; Alpert MA; Webel RR; Ruder MA; Sanfelippo JF; Tsutakawa RK
    Am Heart J; 1985 Aug; 110(2):371-6. PubMed ID: 4025112
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Prognostic value of early electrophysiologic studies for ventricular tachycardia recurrence in patients with coronary artery disease treated with amiodarone.
    Manolis AS; Uricchio F; Estes NA
    Am J Cardiol; 1989 May; 63(15):1052-7. PubMed ID: 2705375
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Prospective evaluation of a discriminant function for prediction of recurrent symptomatic ventricular tachycardia or ventricular fibrillation in coronary artery disease patients receiving amiodarone and having inducible ventricular tachycardia at electrophysiologic study.
    Klein LS; Fineberg N; Heger JJ; Miles WM; Kammerling JM; Chang MS; Zipes DP; Prystowsky EN
    Am J Cardiol; 1988 May; 61(13):1024-30. PubMed ID: 3364357
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Treatment of malignant ventricular tachyarrhythmia with amiodarone: comparison of empirical administration and administration guided by Holter or ventricular stimulation. Results of the parallel test].
    Raviele A; Di Pede F; Gasparini G; Zanocco A; Delise P; Bonso A; D'Este D; Piccolo E
    G Ital Cardiol; 1991 Mar; 21(3):259-69. PubMed ID: 1894120
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Treatment with oral lorcainide in patients with sustained ventricular tachycardia and fibrillation.
    Echt DS; Shapiro M; Trusso J; Mason JW; Winkle RA
    Am Heart J; 1985 Jan; 109(1):28-33. PubMed ID: 3966329
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Use of intravenous amiodarone for emergency treatment of life-threatening ventricular arrhythmias.
    Helmy I; Herre JM; Gee G; Sharkey H; Malone P; Sauve MJ; Griffin JC; Scheinman MM
    J Am Coll Cardiol; 1988 Oct; 12(4):1015-22. PubMed ID: 3417974
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Usefulness of sotalol for drug-refractory malignant ventricular arrhythmias.
    Gonzalez R; Scheinman MM; Herre JM; Griffin JC; Sauve MJ; Sharkey H
    J Am Coll Cardiol; 1988 Dec; 12(6):1568-72. PubMed ID: 3192854
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Determinants of prognosis in symptomatic ventricular tachycardia or ventricular fibrillation late after myocardial infarction. The Dutch Ventricular Tachycardia Study Group of the Interuniversity Cardiology Institute of The Netherlands.
    Willems AR; Tijssen JG; van Capelle FJ; Kingma JH; Hauer RN; Vermeulen FE; Brugada P; van Hoogenhuyze DC; Janse MJ
    J Am Coll Cardiol; 1990 Sep; 16(3):521-30. PubMed ID: 2201710
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Predictors of mortality in patients with sustained ventricular tachycardias or ventricular fibrillation and depressed left ventricular function: importance of beta-blockade.
    Szabó BM; Crijns HJ; Wiesfeld AC; van Veldhuisen DJ; Hillege HL; Lie KI
    Am Heart J; 1995 Aug; 130(2):281-6. PubMed ID: 7631608
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Amiodarone for control of sustained ventricular tachyarrhythmia: clinical and electrophysiologic effects in 51 patients.
    Waxman HL; Groh WC; Marchlinski FE; Buxton AE; Sadowski LM; Horowitz LN; Josephson ME; Kastor JA
    Am J Cardiol; 1982 Nov; 50(5):1066-74. PubMed ID: 6291368
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Nonsustained ventricular tachycardia as a predictor for sudden death in patients with idiopathic dilated cardiomyopathy. The role of amiodarone treatment.
    Castelli G; Ciaccheri M; Cecchi F; Troiani V; Nannini M; Marconi P; Olivotto J; Montereggi A; Dolara A
    G Ital Cardiol; 1999 May; 29(5):514-23. PubMed ID: 10367218
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Efficacy and safety of amiodarone in treatment of refractory atrial and ventricular tachyarrhythmias.
    Kato K
    Ann N Y Acad Sci; 1992 Jan; 644():235-45. PubMed ID: 1562118
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Randomized antiarrhythmic drug therapy in survivors of cardiac arrest (the CASCADE Study). The CASCADE Investigators.
    Am J Cardiol; 1993 Aug; 72(3):280-7. PubMed ID: 8342505
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Induction of ventricular fibrillation predicts sudden death in patients treated with amiodarone because of ventricular tachyarrhythmias after a myocardial infarction.
    Rodríguez LM; Sternick EB; Smeets JL; Timmermans C; den Dulk K; Oreto G; Wellens HJ
    Heart; 1996 Jan; 75(1):23-8. PubMed ID: 8624866
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Amiodarone in patients with previous drug-mediated torsade de pointes. Long-term safety and efficacy.
    Mattioni TA; Zheutlin TA; Sarmiento JJ; Parker M; Lesch M; Kehoe RF
    Ann Intern Med; 1989 Oct; 111(7):574-80. PubMed ID: 2774388
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Management of refractory sustained ventricular tachycardia with amiodarone: a reappraisal.
    Lavery D; Saksena S
    Am Heart J; 1987 Jan; 113(1):49-56. PubMed ID: 3799441
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.